千红制药 (002550.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(千红制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 352,007,088.55394,494,365.85461,101,487.65348,327,597.68409,185,173.54448,537,232.25608,218,905.42
 营业收入(元) 352,007,088.55394,494,365.85461,101,487.65348,327,597.68409,185,173.54448,537,232.25608,218,905.42
二、营业总成本(元) 303,207,121.62309,877,364.35344,356,267.11365,585,336.80363,829,472.97419,405,866.62517,224,547.68
 营业成本(元) 150,572,757.15188,641,414.10216,068,845.29192,790,068.66221,575,654.55245,468,354.29369,499,426.93
 研发费用(元) 29,033,791.8314,411,523.6617,478,054.2243,912,252.9012,169,081.3720,411,369.3720,590,742.37
 营业税金及附加(元) 6,056,051.456,675,562.466,387,200.365,321,830.126,259,123.033,232,936.145,589,014.80
 销售费用(元) 79,969,075.0679,085,519.3478,393,143.3185,120,399.8491,392,028.01129,058,282.5988,286,146.44
 管理费用(元) 34,085,454.5025,685,447.3426,160,279.7238,088,119.6330,850,427.8636,712,864.3026,109,178.54
 财务费用(元) 3,489,991.62-4,622,102.54-131,255.79352,665.651,583,158.15-15,477,940.087,150,038.61
  其中:利息费用(元) 190,905.18255,352.15726,667.20384,740.511,633,292.682,257,745.501,650,620.66
  其中:利息收入(元) -242,368.194,193,769.622,018,292.953,110,244.752,006,387.952,066,243.614,115,184.82
 资产减值损失(元) ----19,614,740.60---1,390.24
 信用减值损失(元) 85,561,708.282,443,805.04-6,064,766.43790,951.728,182,999.31248,076.628,205,439.48
三、其他经营收益
 加:公允价值变动收益(元) 421,265.86428,070.68430,734.45330,539.55116,945.37157,348.86166,547.42
 加:投资收益(元) 4,607,494.38-2,478,864.933,028,237.134,359,130.532,700,342.49662,710.60282,361.41
 资产处置收益(元) ---25,350,273.85---
 其他收益(元) 3,029,564.962,484,477.382,868,043.7916,058,666.503,299,946.752,251,414.592,585,065.83
四、营业利润(元) 142,420,000.4187,544,137.81117,007,469.4810,017,082.4359,656,143.2332,450,916.30102,232,381.64
 加:营业外收入(元) 228,568.361,117,044.171,829.56-25,152,452.3125,361,450.028,029.75133,894.42
 减:营业外支出(元) 388,256.1856,802.91174,400.14117,470.231,001,293.6455,160.4010,042.28
五、利润总额(元) 142,260,312.5988,604,379.07116,834,898.90-15,252,840.1184,016,299.6132,403,785.65102,356,233.78
 减:所得税费用(元) 20,089,706.7213,523,766.5715,488,195.37-6,272,554.9710,033,958.292,283,630.2918,806,406.16
六、净利润(元) 122,170,605.8775,080,612.50101,346,703.53-8,980,285.1473,982,341.3230,120,155.3683,549,827.62
(一)按经营持续性分类
  持续经营净利润(元) 122,170,605.8775,080,612.50101,346,703.53-8,980,285.1473,982,341.3230,120,155.3683,549,827.62
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 126,792,812.0978,684,184.28104,108,160.35-15,994,359.6478,829,270.0233,078,989.2485,946,847.70
  少数股东损益(元) -4,622,206.22-3,603,571.78-2,761,456.827,014,074.50-4,846,928.70-2,958,833.88-2,397,020.08
 扣除非经常性损益后的净利润(元) 48,778,115.4977,475,326.34101,983,572.46-22,312,076.8854,079,645.8626,096,687.0585,617,850.18
七、每股收益
 一、基本每股收益(元) 0.100.060.08-0.010.060.030.07
 二、稀释每股收益(元) 0.100.060.08-0.010.060.030.07
八、其他综合收益(元) 881,427.91580,984.02-1,322,708.981,986,169.47-1,155,970.75-364,869.16-44,827.12
 归属于母公司股东的其他综合收益(元) 881,427.91580,984.02-1,322,708.981,986,169.47-1,155,970.75-364,869.16-44,827.12
九、综合收益总额(元) 123,052,033.7875,661,596.52100,023,994.55-6,994,115.6772,826,370.5729,755,286.2083,505,000.50
 归属于母公司所有者的综合收益总额(元) 127,674,240.0079,265,168.30102,785,451.37-14,008,190.1777,673,299.2732,714,120.0885,902,020.58
 归属于少数股东的综合收益总额(元) -4,622,206.22-3,603,571.78-2,761,456.827,014,074.50-4,846,928.70-2,958,833.88-2,397,020.08
公告日期 2024-10-182024-08-162024-04-262024-04-262023-10-252023-07-222023-04-15
审计意见(境内) 标准无保留意见

前瞻产业研究院